603456 Stock Overview
Manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥14.55 |
52 Week High | CN¥28.16 |
52 Week Low | CN¥11.83 |
Beta | 0.23 |
11 Month Change | -8.14% |
3 Month Change | 18.78% |
1 Year Change | -47.15% |
33 Year Change | -75.73% |
5 Year Change | n/a |
Change since IPO | -57.58% |
Recent News & Updates
Recent updates
Shareholder Returns
603456 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -5.6% | -0.6% | -2.8% |
1Y | -47.1% | -8.7% | 2.0% |
Return vs Industry: 603456 underperformed the CN Pharmaceuticals industry which returned -7.9% over the past year.
Return vs Market: 603456 underperformed the CN Market which returned 3.2% over the past year.
Price Volatility
603456 volatility | |
---|---|
603456 Average Weekly Movement | 7.4% |
Pharmaceuticals Industry Average Movement | 7.4% |
Market Average Movement | 8.4% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 603456 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603456's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1973 | 4,877 | Yi Jiang Mei | www.jiuzhoupharma.com |
Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Fundamentals Summary
603456 fundamental statistics | |
---|---|
Market cap | CN¥13.09b |
Earnings (TTM) | CN¥697.36m |
Revenue (TTM) | CN¥4.91b |
18.8x
P/E Ratio2.7x
P/S RatioIs 603456 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603456 income statement (TTM) | |
---|---|
Revenue | CN¥4.91b |
Cost of Revenue | CN¥3.33b |
Gross Profit | CN¥1.58b |
Other Expenses | CN¥880.59m |
Earnings | CN¥697.36m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.78 |
Gross Margin | 32.12% |
Net Profit Margin | 14.20% |
Debt/Equity Ratio | 5.7% |
How did 603456 perform over the long term?
See historical performance and comparison